{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T05:09:19Z","timestamp":1722661759861},"reference-count":26,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,7,30]]},"DOI":"10.1536\/ihj.20-067","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T22:05:40Z","timestamp":1595023540000},"page":"734-738","source":"Crossref","is-referenced-by-count":3,"title":["B-type Natriuretic Peptide Regulation in Patients with Severe Aortic Stenosis Following Transaortic Valvular Implantation"],"prefix":"10.1536","volume":"61","author":[{"given":"Mitsuo","family":"Sobajima","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Onoda","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kuwahara","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ushijima","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993; 132: 1961-70.","DOI":"10.1210\/en.132.5.1961"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Tsutamoto T, Wada A, Maeda K, <i>et al<\/i>. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-16.","DOI":"10.1161\/01.CIR.96.2.509"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kodali SK, Williams MR, Smith CR, <i>et al<\/i>. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-95.","DOI":"10.1056\/NEJMoa1200384"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Leon MB, Smith CR, Mack MJ, <i>et al<\/i>. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374: 1609-20.","DOI":"10.1056\/NEJMoa1514616"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kodali S, Thourani VH, White J, <i>et al<\/i>. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J 2016; 37: 2252-62.","DOI":"10.1093\/eurheartj\/ehw112"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kefer J, Beauloye C, Astarci P, <i>et al<\/i>. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation. Am J Cardiol 2010; 106: 1782-6.","DOI":"10.1016\/j.amjcard.2010.07.051"},{"key":"7","unstructured":"7. Gotzmann M, Czauderna A, Aweimer A, <i>et al<\/i>. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation. J Heart Valve Dis 2014; 23: 537-44."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ribeiro HB, Urena M, Le Ven F, <i>et al<\/i>. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2014; 113: 851-9.","DOI":"10.1016\/j.amjcard.2013.11.038"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Onoda H, Ueno H, Ueno Y, Kuwahara H, Sobajima M, Kinugawa K. The impact of changes in B-type natriuretic peptide levels on prognosis after transcatheter aortic valve implantation. Cardiovasc Interv Ther 2019 (in press).","DOI":"10.1007\/s12928-019-00621-w"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Baumgartner H, Falk V, Bax JJ, <i>et al<\/i>. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739-91.","DOI":"10.1093\/eurheartj\/ehx391"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nishimura RA, Otto CM, Bonow RO, <i>et al<\/i>. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2438-88.","DOI":"10.1016\/j.jacc.2014.02.537"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50: 2357-68.","DOI":"10.1016\/j.jacc.2007.09.021"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Bergler-Klein J, Mundigler G, Pibarot P, <i>et al<\/i>. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation 2007; 115: 2848-55.","DOI":"10.1161\/CIRCULATIONAHA.106.654210"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Smith CR, Leon MB, Mack MJ, <i>et al<\/i>. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-98.","DOI":"10.1056\/NEJMoa1103510"},{"key":"15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.CIR.73.3.452","volume":"73","year":"1986","unstructured":"15. Zoghbi WA, Farmer KL, Soto JG, Nelson JG, Quinones MA. Accurate noninvasive quantification of stenotic aortic valve area by Doppler echocardiography. Circulation 1986; 73: 452-9.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Iwahashi N, Nakatani S, Umemura S, Kimura K, Kitakaze M. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis. J Am Soc Echocardiogr 2011; 24: 984-91.","DOI":"10.1016\/j.echo.2011.03.012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rassi AN, Pibarot P, Elmariah S. Left ventricular remodelling in aortic stenosis. Can J Cardiol 2014; 30: 1004-11.","DOI":"10.1016\/j.cjca.2014.04.026"},{"key":"18","unstructured":"18. Corrigendum to: &apos;2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure&apos;. Eur Heart J 2018; 39: 1206."},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Anand IS, Fisher LD, Chiang YT, <i>et al<\/i>. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-83.","DOI":"10.1161\/01.CIR.0000054164.99881.00"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Badeer HS. Contractile Tension in the Myocardium. Am Heart J 1963; 66: 432-4.","DOI":"10.1016\/0002-8703(63)90278-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nishimura RA, Otto CM, Bonow RO, <i>et al<\/i>. 2017 AHA\/ACC Focused Update of the 2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135: e1159-95.","DOI":"10.1161\/CIR.0000000000000503"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mizutani K, Hara M, Iwata S, <i>et al<\/i>. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry. J Am Heart Assoc 2017; 6: e006112.","DOI":"10.1161\/JAHA.117.006112"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Koskinas KC, O&apos;Sullivan CJ, Heg D, <i>et al<\/i>. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation. Am J Cardiol 2015; 116: 1560-5.","DOI":"10.1016\/j.amjcard.2015.08.016"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Goel SS, Aksoy O, Gupta S, <i>et al<\/i>. Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study. Ann Intern Med 2014; 161: 699-710.","DOI":"10.7326\/M13-1505"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Andersson C, Abdulla J. Is the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother 2017; 3: 21-7.","DOI":"10.1093\/ehjcvp\/pvw027"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ribeiro GS, Melo RD, Deresz LF, Dal Lago P, Pontes MR, Karsten M. Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: Systematic review and meta-analysis. Eur J Prev Cardiol 2017; 24: 688-97.","DOI":"10.1177\/2047487316686442"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/4\/61_20-067\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T05:39:53Z","timestamp":1667453993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/4\/61_20-067\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-067","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]}}}